Evidence map›Paper›PMID 30988068›Full record

ArticleBioscience reports2019

CircLMTK2 acts as a novel tumor suppressor in gastric cancer.

Jian He, Jie Chen, Ben Ma, Li Jiang, Guangfa Zhao

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. A circular RNA fromAging · 2019
    Article
  16. Current Understanding of Circular RNAs in Gastric Cancer.Cancer management and research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jian HeDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Jie ChenDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Ben MaDepartment of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.
Li JiangDepartment of Orthopedic Surgery, Huashan Hospital, Fudan University, Shanghai, People's Republic of China zhaogf1084@126.com charleyii@163.com.
Guangfa ZhaoDepartment of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China zhaogf1084@126.com charleyii@163.com.ORCID 0000-0002-2570-6216
Shanghai Medical College of Fudan University · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, circRNAs have been found to play regulatory roles in cancer. In the present study, we aimed to investigate the characteristics and effect of circLMTK2, and its potential role as a novel biomarker in cases of gastric cancer (GC). About 111 pairs of clinical tissues from patients were collected for circLMTK2 expression investigation. Afterward, the relationship of circLMTK2 expression level and clinical features, such as survival, tumor size and so on, were analyzed, along with a multivariate Cox hazards analysis. Finally, malignant biological properties, like cell viability and mobility, were explored in cell line MGC-803. We found that circLMTK2 was a stable circRNA generated from the back-spliced Exon 10 and Exon 11 of the LMTK2 gene in GC cells. CircLMTK2 expression was significantly down-regulated in gastric carcinoma tissue specimens (

Indexed as

Genes, Tumor SuppressorCell Line, TumorDisease-Free SurvivalFemaleHumansMaleRNA, CircularRNA, NeoplasmStomach NeoplasmsSurvival RateRNA, CircularRNA, Neoplasmcell migration and invasioncircular RNAgastric cancersurvival

Identifiers

PMID30988068
PMCPMC6527928
OpenAlexW2938476868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.